GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Noritsu Koki Co Ltd (TSE:7744) » Definitions » Debt-to-EBITDA

Noritsu Koki Co (TSE:7744) Debt-to-EBITDA : 3.57 (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Noritsu Koki Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Noritsu Koki Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円15,949 Mil. Noritsu Koki Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円26,628 Mil. Noritsu Koki Co's annualized EBITDA for the quarter that ended in Dec. 2023 was 円11,940 Mil. Noritsu Koki Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 3.57.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Noritsu Koki Co's Debt-to-EBITDA or its related term are showing as below:

TSE:7744' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.18   Med: 5.77   Max: 12.65
Current: 2.18

During the past 13 years, the highest Debt-to-EBITDA Ratio of Noritsu Koki Co was 12.65. The lowest was 2.18. And the median was 5.77.

TSE:7744's Debt-to-EBITDA is ranked worse than
55.38% of 1730 companies
in the Hardware industry
Industry Median: 1.795 vs TSE:7744: 2.18

Noritsu Koki Co Debt-to-EBITDA Historical Data

The historical data trend for Noritsu Koki Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noritsu Koki Co Debt-to-EBITDA Chart

Noritsu Koki Co Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Dec21 Dec22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.52 4.52 12.65 8.13 4.65

Noritsu Koki Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.05 3.80 1.64 1.72 3.57

Competitive Comparison of Noritsu Koki Co's Debt-to-EBITDA

For the Consumer Electronics subindustry, Noritsu Koki Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Noritsu Koki Co's Debt-to-EBITDA Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Noritsu Koki Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Noritsu Koki Co's Debt-to-EBITDA falls into.



Noritsu Koki Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Noritsu Koki Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(19660 + 31417) / 10993
=4.65

Noritsu Koki Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(15949 + 26628) / 11940
=3.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Noritsu Koki Co  (TSE:7744) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Noritsu Koki Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Noritsu Koki Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Noritsu Koki Co (TSE:7744) Business Description

Traded in Other Exchanges
N/A
Address
Azabu Juban 1-10-10 Joule A, 5th Floor, Minato-ku, Tokyo, JPN, 106-0045
Noritsu Koki Co Ltd is a Japan-based company, engaged in the healthcare, drug discovery, senior life, agribusiness food, manufacturing, and other operations. In the manufacturing business, the company manufactures marking pen tip made of felt and synthetic fiber as the main product. In the healthcare business, it offers a range of medical services. In the drug discovery business, the company conducts research and development on biopharmaceuticals and regenerative medicine. The other operations of the company involves the business development and investment research, digital area business and insurance business.

Noritsu Koki Co (TSE:7744) Headlines

No Headlines